{"gene":"NPC2","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2000,"finding":"HE1/NPC2 is a ubiquitously expressed lysosomal protein whose deficiency causes Niemann-Pick type C2 disease; exogenous recombinant NPC2 protein ameliorated lysosomal accumulation of LDL-derived cholesterol in NPC2-deficient fibroblasts, establishing its direct role in cholesterol egress from lysosomes.","method":"Fibroblast complementation assay with recombinant protein, mutation analysis, Western blot","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 / Strong — loss-of-function patient fibroblasts plus protein rescue experiment, replicated across multiple patient samples, foundational disease gene identification","pmids":["11125141"],"is_preprint":false},{"year":1999,"finding":"The porcine NPC2 homolog (HE1 homolog) specifically binds cholesterol with high affinity (Kd = 2.3 µM) in a 1:1 stoichiometry, establishing NPC2 as a cholesterol-binding protein.","method":"In vitro cholesterol binding assay with purified protein, stoichiometry determination","journal":"Biochimica et biophysica acta","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct in vitro biochemical binding assay with purified protein; replicated in subsequent human studies","pmids":["10366780"],"is_preprint":false},{"year":2007,"finding":"Crystal structure of bovine NPC2 bound to cholesterol-3-O-sulfate revealed that the sterol binds in a deep hydrophobic pocket between two β-sheets, with only the sulfate substituent exposed to solvent; two aromatic residues at the tunnel entrance are repositioned upon sterol binding and are essential for NPC2 function.","method":"X-ray crystallography (apo and sterol-bound forms), structural analysis","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure at atomic resolution with both apo and bound forms, functionally validated by mutagenesis data from complementary studies","pmids":["17573352"],"is_preprint":false},{"year":2008,"finding":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 N-terminal domain (NTD) and phosphatidylcholine liposomes; NPC2 accelerates cholesterol transfer between NPC1(NTD) and liposomes >100-fold; the naturally occurring P120S mutant of NPC2 fails to bind cholesterol and fails to stimulate this transfer, establishing NPC2 as an essential intermediary in lysosomal cholesterol handoff to NPC1.","method":"In vitro cholesterol transfer assay with [3H]cholesterol, liposomes, and purified recombinant proteins; mutagenesis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — reconstituted in vitro transfer assay with mutagenesis validation, rigorous quantitative measurements","pmids":["18772377"],"is_preprint":false},{"year":2004,"finding":"Genetic epistasis analysis using NPC1;NPC2 double-mutant mice showed that NPC1 and NPC2 single mutants and double mutants have identical or similar phenotypes in disease onset, pathology, neuronal storage, and lipid biochemistry, providing genetic evidence that NPC1 and NPC2 function in concert (non-redundantly) to facilitate lysosomal lipid egress.","method":"Double-mutant mouse genetics, biochemical lipid analysis, histopathology","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis in mouse model with multiple phenotypic readouts across labs","pmids":["15071184"],"is_preprint":false},{"year":2011,"finding":"The second lumenal domain (MLD) of NPC1 binds directly to NPC2, and this interaction is only detected at acidic pH and requires cholesterol to be bound to NPC2, supporting directional cholesterol transfer from NPC2 to NPC1's N-terminal domain. Disease-causing mutations in NPC1 domain 2 decrease NPC2 binding.","method":"Surface plasmon resonance, affinity chromatography, engineered soluble NPC1 domain constructs","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — SPR binding assay plus affinity chromatography, pH-dependence and cholesterol-dependence validated, disease mutation analysis included","pmids":["22065762"],"is_preprint":false},{"year":2016,"finding":"Crystal structure at 2.4-Å resolution of the human NPC1 middle lumenal domain (MLD) bound to NPC2 carrying cholesterol-3-O-sulfate revealed that NPC1-MLD uses two protruding loops to bind NPC2 (analogous to Ebola virus glycoprotein interaction). Docking onto full-length NPC1 reveals a direct cholesterol transfer tunnel between NPC2 and NPC1 NTD binding pockets, supporting the 'hydrophobic hand-off' model.","method":"X-ray crystallography (2.4-Å), structural docking analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Moderate — atomic-resolution crystal structure of the protein complex with ligand, structural docking analysis","pmids":["27551080"],"is_preprint":false},{"year":2006,"finding":"NPC2 consists of multiple N-glycoforms; mass spectrometry revealed that Asn-19 is not glycosylated, Asn-39 carries Endo H-sensitive oligosaccharide, and Asn-116 is variably utilized. NPC2 binds a range of cholesterol-related molecules (cholesterol precursors, plant sterols, some oxysterols, cholesterol sulfate) but not glycolipids, phospholipids, or fatty acids, and forms an equimolar complex with dehydroergosterol.","method":"Mass spectrometry, cation-exchange chromatography-based binding assay, endoglycosidase treatment, fluorescence binding assay","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biochemical methods in single study (MS, chromatography-based binding, fluorescence)","pmids":["17018531"],"is_preprint":false},{"year":2004,"finding":"N-glycosylation at Asn-58 (but not Asn-135) is required for proper lysosomal targeting of NPC2; only the oligosaccharide at Asn-58 is responsible for targeting to lysosomes and is crucial for NPC2 function in restoring normal cholesterol trafficking in NPC2-deficient cells.","method":"Site-directed mutagenesis of glycosylation sites, immunocytofluorescence microscopy in NPC2-/- fibroblasts, cholesterol trafficking complementation assay","journal":"Molecular genetics and metabolism","confidence":"High","confidence_rationale":"Tier 2 / Moderate — mutagenesis combined with functional complementation and subcellular localization in disease cell model","pmids":["15542393"],"is_preprint":false},{"year":2008,"finding":"NPC2 transfers cholesterol from membranes to the protein and between membranes via a mechanism involving direct protein-membrane interaction (confirmed by FTIR spectroscopy and tryptophan spectral shifts); the lysosomal phospholipid lyso-bisphosphatidic acid (LBPA) greatly enhances NPC2-mediated cholesterol transfer rates by up to 2 orders of magnitude.","method":"Fluorescence spectroscopy cholesterol transfer assay, FTIR spectroscopy, tryptophan fluorescence spectroscopy","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal biophysical methods in single study establishing mechanism and LBPA stimulation","pmids":["18823126"],"is_preprint":false},{"year":2019,"finding":"NPC2 interacts directly with LBPA, and the NPC2 hydrophobic knob domain is the site of this interaction; LBPA enrichment in NPC2-deficient human cells is entirely ineffective at clearing cholesterol (unlike in NPC1-deficient cells), establishing an obligate functional interaction between NPC2 and LBPA in intracellular cholesterol trafficking.","method":"Direct binding assay (LBPA-NPC2 interaction), lipid enrichment of patient fibroblasts, domain mapping mutagenesis","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 / Moderate — direct binding assay plus functional complementation in patient cells plus domain-level mapping","pmids":["31580258"],"is_preprint":false},{"year":2010,"finding":"NPC2 mediates cholesterol transfer between liposomes and stimulates membrane fusion; BMP (bis(monoacylglycero)phosphate) greatly stimulates NPC2-mediated cholesterol transfer, while sphingomyelin inhibits it; ceramide, produced from sphingomyelin hydrolysis, enhances transfer. NPC2 shows specificity for cholesterol over other lipids including ceramide, GM3, phosphatidylethanolamine, and phosphatidylserine.","method":"In vitro liposome cholesterol transfer assay with fluorescent/biotinylated vesicles, membrane fusion assay","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 / Moderate — quantitative in vitro reconstitution with defined lipid compositions, specificity tested for multiple lipid species","pmids":["20179319"],"is_preprint":false},{"year":2014,"finding":"Acid sphingomyelinase (ASM)-mediated hydrolysis of sphingomyelin to ceramide in late endosomal membranes is required for physiological NPC2-mediated cholesterol transfer; ASM stimulates NPC2-dependent cholesterol export from the late endosomal compartment.","method":"Liposomal cholesterol transfer assay with ASM preincubation, lipid composition manipulation","journal":"Journal of lipid research","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro liposome assay, single lab, mechanistic link established but not independently replicated","pmids":["25339683"],"is_preprint":false},{"year":2017,"finding":"The GARP complex (containing VPS53) is required for CI-MPR-dependent sorting/trafficking of NPC2 to lysosomes; depletion of GARP subunits impaired NPC2 lysosomal delivery, blocked CI-MPR retrieval to the trans-Golgi network, and caused cholesterol accumulation. Vps54 mutant mice displayed reduced NPC2 protein levels and increased cholesterol accumulation.","method":"Genome-wide CRISPR/amphotericin B selection screen, siRNA knockdown, whole-transcriptome sequencing, mouse genetics","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — unbiased genetic screen plus functional validation in cells and mouse model with defined mechanistic pathway","pmids":["28658628"],"is_preprint":false},{"year":2003,"finding":"NPC1 governs the endocytic transport of NPC2: NPC1 mutations cause NPC2 to accumulate in and become upregulated in cholesterol-storing late endocytic organelles; a greater proportion of NPC2 becomes membrane-associated in NPC1 mutant late endosomes compared to wild-type.","method":"Subcellular fractionation of mouse liver late endosomes by magnetic chromatography, Western blotting, immunofluorescence","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — fractionation and localization in NPC1 mutant cells, single lab","pmids":["12554680"],"is_preprint":false},{"year":2005,"finding":"NPC2 is present in an incompletely deglycosylated form in NPC1 late endosomes by a mechanism specific to NPC2 (secreted NPC2 from NPC1 cells is normal); a greater proportion of NPC2 partitions with detergent-insoluble late endosomal internal membrane domains in NPC1 vesicles.","method":"Magnetic chromatography isolation of late endosomes, Endo H/PNGase F treatment, Western blotting, detergent fractionation","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — biochemical fractionation with specific enzymatic controls, single lab","pmids":["15896196"],"is_preprint":false},{"year":2004,"finding":"NPC2/HE1 is localized predominantly in neurons (especially pyramidal cells of cerebral cortex, amygdala, and Purkinje cells) and is present in the cytosol of dendrites and on postsynaptic densities (PSD) of neurons, as confirmed by electron microscopic immunocytochemistry and Western blot of PSD-enriched fractions.","method":"Immunocytochemistry, electron microscopic immunocytochemistry, subcellular fractionation, Western blotting","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct electron microscopic localization and fractionation, single lab, functional consequence not directly tested","pmids":["15381285"],"is_preprint":false},{"year":2006,"finding":"NPC2 is expressed in liver and secreted into bile and plasma; hepatic NPC2 protein expression is dramatically increased in NPC1-deficient mice; biliary NPC2 is exclusively found in the cholesterol pro-nucleating ConA-binding fraction of human bile.","method":"Western blotting of bile and plasma fractions, ConA-binding fractionation, NPC1 knockout mouse analysis","journal":"Hepatology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — protein fractionation and mouse genetics, single lab, functional role in bile inferred","pmids":["16374838"],"is_preprint":false},{"year":2011,"finding":"Secreted NPC2 stimulates ABCG5/G8-mediated biliary cholesterol efflux but not NPC1L1-mediated cholesterol uptake; hepatic NPC2 overexpression failed to increase biliary cholesterol in ABCG5/G8-null mice, demonstrating that NPC2 requires ABCG5/G8 to stimulate biliary cholesterol secretion. This function was shown to be independent of NPC2's lysosomal cholesterol trafficking function.","method":"Adenovirus-mediated hepatic knockdown/overexpression in mice, biliary lipid analysis, in vitro transporter activity assay, ABCG5/G8-null mouse experiment","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vivo mouse genetics with defined null background plus in vitro mechanistic confirmation, multiple complementary approaches","pmids":["21315718"],"is_preprint":false},{"year":2017,"finding":"Atomistic MD simulations identified two competitive membrane binding orientations of NPC2: a 'Prone' mode placing the cholesterol binding pocket in contact with the membrane (associated with cholesterol uptake/release, requires BMP specifically) and a 'Supine' mode with the pocket away from membrane. BMP is specifically required for strong Prone mode binding; sphingomyelin counteracts BMP by hindering Prone mode.","method":"Atomistic molecular dynamics simulations, free energy calculations","journal":"PLoS computational biology","confidence":"Low","confidence_rationale":"Tier 4 / Weak — computational only, no experimental validation in same study, consistent with experimental LBPA/BMP data","pmids":["29084218"],"is_preprint":false},{"year":2018,"finding":"The non-canonical NF-κB pathway (NF-κB2) directly activates NPC2 transcription by binding its promoter; disruption of NF-κB2 or other non-canonical pathway members suppresses NPC2 expression and causes intracellular cholesterol accumulation; LTβR or BaffR stimulation upregulates NPC2 mRNA and protein.","method":"RNAi knockdown, promoter binding assay (ChIP), qPCR, cholesterol accumulation assay, NF-κB2-deficient zebrafish embryos and mice","journal":"Science China. Life sciences","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct promoter binding plus loss-of-function in cells and in vivo models, single lab","pmids":["30091016"],"is_preprint":false},{"year":2023,"finding":"TMEM241, a Golgi-localized UDP-GlcNAc transporter, is required for mannose-6-phosphate (M6P) modification of NPC2; ablation of TMEM241 impairs M6P-dependent lysosomal targeting of NPC2, causing cholesterol accumulation in lysosomes. Tmem241-deficient mice display cholesterol accumulation in pulmonary cells.","method":"Genome-wide CRISPR-Cas9 KO screen (amphotericin B-based), TMEM241 KO cell characterization, M6P modification assay, mouse knockout","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — unbiased genetic screen plus mechanistic validation (M6P modification assay), in vivo mouse model confirmation","pmids":["37890669"],"is_preprint":false},{"year":2022,"finding":"The BORC-ARL8-HOPS ensemble is required for CI-MPR-dependent trafficking of NPC2 to lysosomes; depletion of BORC, ARL8, or HOPS decreases NPC2 lysosomal association, increases NPC2 secretion, increases lysosomal degradation of CI-MPR, and impairs cholesterol egress—without altering NPC1 localization.","method":"siRNA knockdown, filipin staining, NPC2 localization by immunofluorescence, CI-MPR trafficking assay, cholesterol esterification assay","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple knockdown targets tested, defined pathway placement, single lab","pmids":["35653304"],"is_preprint":false},{"year":2009,"finding":"NPC2 is identified as a binding partner of the C2 domain of human Nedd4L (E3 ubiquitin ligase); NPC2 is expressed along the aldosterone-sensitive distal nephron co-localizing with Nedd4L, and NPC2 transcription/activation is regulated by sodium intake in a salt-sensitive hypertension model, suggesting NPC2 may regulate sodium reabsorption by interacting with the ENaC-Nedd4L system.","method":"Yeast two-hybrid screening, co-localization immunohistochemistry, Dahl rat salt-sensitive model","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — yeast two-hybrid binding (not confirmed by reciprocal Co-IP), functional consequence inferred from expression data, single lab","pmids":["19664597"],"is_preprint":false},{"year":2014,"finding":"ATRA-triggered antimicrobial activity against M. tuberculosis requires NPC2 expression; NPC2 knockdown abolishes ATRA-induced decrease in total cellular cholesterol and increase in lysosomal acidification, and ablates ATRA-induced antimicrobial activity against M. tuberculosis.","method":"siRNA knockdown, cholesterol quantification, lysosomal acidification assay, intracellular M. tuberculosis killing assay","journal":"Journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function with defined functional readouts, single lab, mechanism beyond cholesterol regulation not fully defined","pmids":["24501203"],"is_preprint":false},{"year":2015,"finding":"NPC2 secreted from premalignant lung tumour cells is taken up by immature macrophage-lineage cells (IMCs) where it suppresses secretion of CCL6 (at least partly by facilitating its lysosomal degradation), thereby restraining CCR1-dependent IMC recruitment to the tumour microenvironment.","method":"NPC2 knockout/overexpression in mouse lung tumor model, ex vivo cell secretion assay, CCL6 measurement, IMC recruitment assay in vivo","journal":"EMBO molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — combined in vivo and ex vivo experiments with defined mechanistic readouts, single lab","pmids":["26183450"],"is_preprint":false},{"year":2009,"finding":"NPC2-deficient female mice exhibit anovulation, abnormal estrous cycles, and infertility with reduced serum estradiol and accumulated ovarian cholesterol; NPC2 localizes to theca and luteal cells, establishing a role for NPC2 in ovarian cholesterol export for steroid synthesis.","method":"NPC2 knockout mouse model, immunohistochemistry, hormone measurements, filipin staining, superovulation experiments","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function mouse model with defined endocrine phenotype and localization, single lab","pmids":["19883728"],"is_preprint":false},{"year":2014,"finding":"Epididymal spermatozoa from NPC2-/- mice have reduced cholesterol content and show defective tyrosine phosphorylation patterns during capacitation and reduced in vitro fertilization ability, establishing NPC2 as a regulator of sperm cholesterol content during epididymal maturation required for fertility.","method":"NPC2 knockout mouse model, biochemical cholesterol quantification, flow cytometry, Western blot for tyrosine phosphorylation, in vitro fertilization assay","journal":"Reproduction, fertility, and development","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — loss-of-function knockout with multiple defined functional readouts, single lab","pmids":["24709320"],"is_preprint":false},{"year":2016,"finding":"NEGR1 interacts with NPC2 and increases its protein stability; ectopic NEGR1 expression relieves abnormal cholesterol accumulation in endosomal compartments; NEGR1-deficient mouse embryonic fibroblasts exhibit increased cholesterol levels and triglyceride contents.","method":"Co-immunoprecipitation, cholesterol accumulation assay (filipin staining), NEGR1 knockout MEFs","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single Co-IP plus functional assay, single lab, mechanism of stability regulation not fully defined","pmids":["27940359"],"is_preprint":false},{"year":2004,"finding":"NPC2/HE1 secretion from astrocytes is not inhibited by loss of NPC1 function; the majority of sterols secreted from astrocytes are not co-secreted with NPC2 protein, as shown by size-exclusion chromatography with electron microscopy demonstrating separate particles.","method":"Size-exclusion chromatography, electron microscopy, Western blot of astrocyte conditioned medium from NPC1-/- and wild-type cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct separation and visualization by orthogonal methods, NPC1-/- mouse astrocytes","pmids":["15355983"],"is_preprint":false},{"year":2025,"finding":"SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by binding HOPS subunit VPS39, which traps CI-MPR and retromer in endosomes/lysosomes, impairing NPC2 trafficking to lysosomes; additionally, ORF3a reduces BMP levels by decreasing lysosome-mitochondrion membrane contact sites in a VPS39-dependent manner, identifying VPS39 as a regulator of NPC2 trafficking.","method":"Co-immunoprecipitation (ORF3a-VPS39), retromer/CI-MPR localization, NPC2 trafficking assay, lipidomics, proteomics, mitochondria-lysosome contact site quantification, VPS39/retromer deletion experiments","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods, preprint not yet peer-reviewed, mechanistic detail well-supported within the study","pmids":["39605369"],"is_preprint":true},{"year":2025,"finding":"NPC2 deficiency results in reduced mitochondria-late endosome/lysosome contact sites, accumulation of glucosylsphingosine, glucosylceramides, sphingosine, and sphingomyelins in lysosomes, and swollen lipid-dense acidic compartments—without overt oxidative stress changes.","method":"NPC2-/- HEK cell model, mass spectrometry lipidomics, contact site quantification by fluorescence microscopy, organelle morphology analysis","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — multiple orthogonal methods (lipidomics, imaging) in defined KO model, single lab, preprint/recent publication","pmids":["39747180"],"is_preprint":false}],"current_model":"NPC2 is a small soluble lysosomal glycoprotein that binds cholesterol in a deep hydrophobic pocket (crystal structure resolved) and functions as the primary intraluminal cholesterol carrier: it accepts cholesterol from internal lysosomal membranes (a process stimulated by the lysosomal phospholipid LBPA/BMP via direct NPC2-LBPA interaction at the NPC2 hydrophobic knob domain), then docks onto the middle lumenal domain of the membrane protein NPC1 (interaction requiring acidic pH and cholesterol-loaded NPC2) to hand off cholesterol through a direct tunnel to NPC1's N-terminal domain for export to the cytosol; the two proteins act non-redundantly in concert as shown by double-mutant mouse genetics. NPC2 reaches lysosomes via mannose-6-phosphate-dependent sorting through the CI-MPR pathway, which is regulated by the GARP complex, the BORC-ARL8-HOPS ensemble, and TMEM241-mediated UDP-GlcNAc supply for M6P modification; the non-canonical NF-κB2 pathway directly controls NPC2 transcription. Beyond lysosomes, secreted NPC2 stimulates ABCG5/G8-dependent biliary cholesterol secretion, regulates ovarian steroidogenesis by providing cholesterol substrate, controls sperm cholesterol content during epididymal maturation, and in the innate immune context mediates ATRA-induced antimicrobial activity against M. tuberculosis through lysosomal acidification and cholesterol reduction."},"narrative":{"mechanistic_narrative":"NPC2 is a small soluble lysosomal glycoprotein that serves as the primary intraluminal cholesterol carrier, and its deficiency causes Niemann-Pick type C2 disease, with exogenous recombinant NPC2 rescuing lysosomal cholesterol accumulation in patient fibroblasts [PMID:11125141]. It binds cholesterol with high affinity in a 1:1 stoichiometry [PMID:10366780], sequestering the sterol in a deep hydrophobic pocket between two β-sheets with only the polar substituent solvent-exposed and aromatic tunnel-entrance residues essential for function [PMID:17573352]; binding is selective for cholesterol and closely related sterols over phospholipids, glycolipids, and fatty acids [PMID:17018531]. NPC2 extracts cholesterol from internal lysosomal membranes through direct protein-membrane contact, a process accelerated by orders of magnitude by the lysosomal phospholipid LBPA/BMP via a direct interaction at the NPC2 hydrophobic knob, while sphingomyelin inhibits and ceramide promotes transfer [PMID:18823126, PMID:31580258, PMID:20179319]. NPC2 then docks onto the middle lumenal domain of NPC1 — an interaction requiring acidic pH and cholesterol-loaded NPC2 — to hand cholesterol through a direct tunnel to NPC1's N-terminal domain for export [PMID:18772377, PMID:22065762, PMID:27551080]; mouse double-mutant genetics establishes that NPC1 and NPC2 act non-redundantly in concert in this egress pathway [PMID:15071184]. NPC2 reaches lysosomes by mannose-6-phosphate-dependent CI-MPR sorting that depends on TMEM241-supplied UDP-GlcNAc for M6P modification, the GARP complex, and the BORC-ARL8-HOPS ensemble [PMID:37890669, PMID:28658628, PMID:35653304], with Asn-58 glycosylation required for correct targeting [PMID:15542393], and its transcription is directly driven by the non-canonical NF-κB2 pathway [PMID:30091016]. Beyond lysosomal egress, secreted NPC2 stimulates ABCG5/G8-dependent biliary cholesterol secretion independently of its lysosomal function [PMID:21315718], supports ovarian steroidogenesis and sperm maturation by providing cholesterol [PMID:19883728, PMID:24709320], and mediates ATRA-induced antimicrobial activity against M. tuberculosis through lysosomal acidification and cholesterol reduction [PMID:24501203].","teleology":[{"year":1999,"claim":"Before any function was assigned, it was unknown whether NPC2 acted on lipids directly; demonstrating high-affinity 1:1 cholesterol binding established it as a dedicated cholesterol-binding protein.","evidence":"In vitro cholesterol binding assay with purified porcine NPC2 homolog","pmids":["10366780"],"confidence":"High","gaps":["Binding alone did not establish a transport function","Did not reveal the structural basis of recognition"]},{"year":2000,"claim":"It was unclear whether NPC2 directly mediates cholesterol egress; rescue of LDL-cholesterol accumulation in NPC2-deficient fibroblasts by recombinant protein established NPC2 as causally required for lysosomal cholesterol export and the gene behind NPC2 disease.","evidence":"Fibroblast complementation with recombinant protein, mutation analysis","pmids":["11125141"],"confidence":"High","gaps":["Did not define the molecular partner receiving cholesterol","Mechanism of membrane extraction unresolved"]},{"year":2004,"claim":"Whether NPC1 and NPC2 act in the same pathway or in parallel was unresolved; identical single- and double-mutant mouse phenotypes provided genetic evidence they function non-redundantly in concert.","evidence":"NPC1;NPC2 double-mutant mouse genetics with biochemical and histopathological readouts","pmids":["15071184"],"confidence":"High","gaps":["Genetic epistasis did not show physical handoff","Order and directionality of transfer not established"]},{"year":2004,"claim":"The basis of NPC2 lysosomal targeting was unknown; mutagenesis showed glycosylation at Asn-58 specifically directs NPC2 to lysosomes and is required for its trafficking function.","evidence":"Site-directed mutagenesis of glycosylation sites with localization and complementation in NPC2-/- fibroblasts","pmids":["15542393"],"confidence":"High","gaps":["Did not identify the sorting receptor or machinery","M6P dependence inferred but not directly demonstrated here"]},{"year":2006,"claim":"The breadth of NPC2 ligand specificity and its glycoform heterogeneity were unclear; biochemical profiling defined selective binding to cholesterol and related sterols but not other lipids, and mapped variable N-glycan usage.","evidence":"Mass spectrometry, chromatography-based and fluorescence binding assays, endoglycosidase treatment","pmids":["17018531"],"confidence":"High","gaps":["Did not connect specific glycoforms to function","Physiological relevance of each ligand untested"]},{"year":2007,"claim":"How NPC2 holds cholesterol was unknown at atomic detail; the crystal structure revealed a deep hydrophobic pocket with conformationally mobile aromatic gate residues essential for function.","evidence":"X-ray crystallography of apo and sterol-bound bovine NPC2","pmids":["17573352"],"confidence":"High","gaps":["Did not show how the sterol enters or exits","Structure of the NPC1-bound transfer state not defined"]},{"year":2008,"claim":"The receiver of NPC2-bound cholesterol was unknown; reconstitution showed NPC2 accelerates bidirectional transfer between NPC1's NTD and membranes >100-fold and that a cholesterol-binding-deficient mutant fails, placing NPC2 as the essential intermediary in handoff to NPC1.","evidence":"In vitro [3H]cholesterol transfer assay with purified NPC1-NTD, liposomes, and P120S mutant","pmids":["18772377"],"confidence":"High","gaps":["Did not capture the NPC2-NPC1 docking interface","Directionality in vivo not established"]},{"year":2008,"claim":"How NPC2 engages membranes and what regulates transfer rate was unclear; biophysics demonstrated direct protein-membrane interaction and showed LBPA enhances transfer up to two orders of magnitude.","evidence":"Fluorescence and FTIR spectroscopy, tryptophan spectral shifts, cholesterol transfer assays","pmids":["18823126"],"confidence":"High","gaps":["Did not map the LBPA interaction site","Membrane-bound orientation not resolved"]},{"year":2010,"claim":"The lipid context governing NPC2 transfer was undefined; defined-liposome assays showed BMP stimulates and sphingomyelin inhibits transfer while ceramide enhances it, with strong selectivity for cholesterol.","evidence":"In vitro liposome cholesterol transfer and membrane fusion assays with defined lipids","pmids":["20179319"],"confidence":"High","gaps":["Did not establish in vivo lipid regulation","Membrane fusion role physiological relevance untested"]},{"year":2011,"claim":"How NPC2 transfers cargo to NPC1 mechanistically was unknown; SPR and affinity studies showed NPC1's middle lumenal domain binds NPC2 only at acidic pH with cholesterol bound, and disease mutations weaken binding, defining a regulated docking step.","evidence":"Surface plasmon resonance, affinity chromatography, engineered soluble NPC1 domains","pmids":["22065762"],"confidence":"High","gaps":["Did not provide atomic structure of the complex","Tunnel for transfer not visualized"]},{"year":2016,"claim":"The structural basis of the handoff was unresolved; the NPC1-MLD/NPC2 co-crystal revealed two protruding loops binding NPC2 and a direct cholesterol transfer tunnel between the two binding pockets, supporting the hydrophobic hand-off model.","evidence":"2.4-Å X-ray crystallography of the complex and docking onto full-length NPC1","pmids":["27551080"],"confidence":"High","gaps":["Static structure did not capture the transfer in motion","Membrane-embedded NPC1 export step not resolved"]},{"year":2014,"claim":"Whether sphingomyelin metabolism gates NPC2 function was unclear; ASM-mediated conversion of sphingomyelin to ceramide was shown to be required for physiological NPC2 cholesterol transfer.","evidence":"Liposomal cholesterol transfer assays with ASM preincubation","pmids":["25339683"],"confidence":"Medium","gaps":["In vitro only, not independently replicated","Cellular consequence of ASM loss on NPC2 not directly tested"]},{"year":2019,"claim":"Whether the LBPA stimulation reflects a direct interaction was uncertain; direct binding and domain mapping localized the LBPA interaction to the NPC2 hydrophobic knob and showed LBPA enrichment cannot rescue NPC2-deficient cells, establishing an obligate functional partnership.","evidence":"Direct LBPA-NPC2 binding assay, lipid enrichment of patient fibroblasts, domain-mapping mutagenesis","pmids":["31580258"],"confidence":"High","gaps":["Did not resolve the LBPA-binding structure","Stoichiometry of NPC2-LBPA-membrane complex unknown"]},{"year":2017,"claim":"The membrane-engaged conformations of NPC2 were inferred but not modeled; MD simulations defined competing Prone and Supine orientations with BMP specifically favoring the uptake-competent Prone mode.","evidence":"Atomistic molecular dynamics simulations and free energy calculations","pmids":["29084218"],"confidence":"Low","gaps":["Computational only, no experimental validation in the same study","Predicted orientations not directly observed structurally"]},{"year":2017,"claim":"The trafficking machinery delivering NPC2 to lysosomes was undefined; a CRISPR screen identified the GARP complex as required for CI-MPR-dependent NPC2 delivery, linking GARP loss to cholesterol accumulation.","evidence":"Genome-wide CRISPR screen, siRNA validation, transcriptomics, Vps54 mutant mice","pmids":["28658628"],"confidence":"High","gaps":["Did not establish the full sorting receptor cycle","Other trafficking regulators not yet identified"]},{"year":2022,"claim":"Additional regulators of NPC2 lysosomal delivery were unknown; depletion of BORC, ARL8, or HOPS reduced NPC2 lysosomal association and increased its secretion via destabilized CI-MPR, without affecting NPC1.","evidence":"siRNA knockdown, filipin staining, CI-MPR trafficking and cholesterol esterification assays","pmids":["35653304"],"confidence":"Medium","gaps":["Single lab","Direct interactions among components not mapped"]},{"year":2023,"claim":"How NPC2 acquires its M6P sorting signal was unresolved; a CRISPR screen identified TMEM241 as the Golgi UDP-GlcNAc transporter required for M6P modification and lysosomal targeting of NPC2.","evidence":"Genome-wide CRISPR-Cas9 screen, M6P modification assay, TMEM241 KO cells and mice","pmids":["37890669"],"confidence":"High","gaps":["Did not test whether other lysosomal enzymes share this dependence specificity","Tissue selectivity of the phenotype unexplained"]},{"year":2018,"claim":"Transcriptional control of NPC2 was unknown; ChIP and loss-of-function across species showed the non-canonical NF-κB2 pathway directly drives NPC2 transcription and that its loss causes cholesterol accumulation.","evidence":"ChIP promoter binding, RNAi, qPCR, NF-κB2-deficient zebrafish and mice","pmids":["30091016"],"confidence":"Medium","gaps":["Single lab","Upstream physiological triggers in tissues not defined"]},{"year":2006,"claim":"It was unknown whether NPC2 acts outside lysosomes; detection of secreted NPC2 in bile and plasma, enriched in the cholesterol pro-nucleating bile fraction and upregulated in NPC1-null liver, pointed to an extracellular role.","evidence":"Western blotting of bile/plasma fractions, ConA fractionation, NPC1 KO mice","pmids":["16374838"],"confidence":"Medium","gaps":["Functional role in bile only inferred","Mechanism of secretion not defined"]},{"year":2011,"claim":"Whether secreted NPC2 functionally affects biliary cholesterol was untested; mouse genetics showed NPC2 stimulates ABCG5/G8-mediated biliary cholesterol efflux, requiring those transporters and independent of its lysosomal function.","evidence":"Adenoviral hepatic knockdown/overexpression, biliary lipid analysis, ABCG5/G8-null mice","pmids":["21315718"],"confidence":"High","gaps":["Molecular interaction between NPC2 and ABCG5/G8 not shown","Whether NPC2 delivers cholesterol to the transporters undefined"]},{"year":2009,"claim":"A physiological role for NPC2 in steroidogenic tissue was unknown; NPC2-deficient female mice showed anovulation, low estradiol, and ovarian cholesterol accumulation, implicating NPC2 in cholesterol export for steroid synthesis.","evidence":"NPC2 KO mice, immunohistochemistry, hormone assays, superovulation","pmids":["19883728"],"confidence":"Medium","gaps":["Mechanism of cholesterol delivery to steroidogenic machinery not defined","Single lab"]},{"year":2014,"claim":"Whether NPC2 governs sperm cholesterol was unknown; NPC2-/- epididymal sperm showed reduced cholesterol, abnormal capacitation-associated phosphorylation, and impaired fertilization, defining a role in epididymal maturation.","evidence":"NPC2 KO mice, cholesterol quantification, tyrosine phosphorylation Western blot, IVF assay","pmids":["24709320"],"confidence":"Medium","gaps":["Direct cholesterol transfer to sperm membranes not demonstrated","Single lab"]},{"year":2014,"claim":"A role for NPC2 in innate immunity was unexplored; NPC2 knockdown abolished ATRA-induced cholesterol reduction, lysosomal acidification, and antimicrobial killing of M. tuberculosis.","evidence":"siRNA knockdown, cholesterol and lysosomal acidification assays, intracellular M. tuberculosis killing","pmids":["24501203"],"confidence":"Medium","gaps":["Mechanism linking cholesterol to acidification and killing not fully defined","Single lab"]},{"year":2015,"claim":"Whether tumor-secreted NPC2 has a signaling role was unknown; NPC2 taken up by immature myeloid cells suppressed CCL6 secretion via lysosomal degradation, restraining CCR1-dependent recruitment to premalignant lung tissue.","evidence":"NPC2 KO/overexpression mouse lung tumor model, ex vivo secretion assays, IMC recruitment in vivo","pmids":["26183450"],"confidence":"Medium","gaps":["Mechanism of CCL6 degradation control not detailed","Generality beyond this model unknown"]},{"year":2003,"claim":"How NPC1 status affects NPC2 was unclear; fractionation showed NPC1 mutation causes NPC2 to accumulate, become upregulated, and shift toward membrane association in storage organelles.","evidence":"Magnetic chromatography of late endosomes, Western blot, immunofluorescence","pmids":["12554680"],"confidence":"Medium","gaps":["Did not establish whether membrane shift is cause or consequence","Single lab"]},{"year":2025,"claim":"The cellular lipid and organelle consequences of NPC2 loss beyond cholesterol were unclear; an NPC2-/- model showed accumulation of sphingolipids, reduced mitochondria-lysosome contacts, and swollen acidic compartments without oxidative stress.","evidence":"NPC2-/- HEK cells, lipidomics, contact site quantification, morphology analysis","pmids":["39747180"],"confidence":"Medium","gaps":["Causal link between cholesterol block and sphingolipid accumulation not dissected","Single lab"]},{"year":null,"claim":"The mechanism coupling NPC2 cholesterol handling to organelle membrane contact sites and how its diverse extracellular functions are coordinated with its lysosomal role remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structure of the membrane-engaged NPC2 transfer state","Mechanism of NPC2-ABCG5/G8 cooperation undefined","Integration of innate-immune and reproductive roles with core trafficking unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[1,2,7,9,11]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[3,9,11]},{"term_id":"GO:0140313","term_label":"molecular sequestering activity","supporting_discovery_ids":[2,3]}],"localization":[{"term_id":"GO:0005764","term_label":"lysosome","supporting_discovery_ids":[0,8,13,21,22]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[14,15,28]},{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[17,18,29]}],"pathway":[{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[0,3,18]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[8,13,21,22]},{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[13,22]}],"complexes":[],"partners":["NPC1","LBPA/BMP"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P61916","full_name":"NPC intracellular cholesterol transporter 2","aliases":["Epididymal secretory protein E1","Human epididymis-specific protein 1","He1","Niemann-Pick disease type C2 protein"],"length_aa":151,"mass_kda":16.6,"function":"Intracellular cholesterol transporter which acts in concert with NPC1 and plays an important role in the egress of cholesterol from the lysosomal compartment (PubMed:11125141, PubMed:15937921, PubMed:17018531, PubMed:18772377, PubMed:29580834). Unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes is transferred by NPC2 to the cholesterol-binding pocket in the N-terminal domain of NPC1 (PubMed:17018531, PubMed:18772377, PubMed:27238017). May bind and mobilize cholesterol that is associated with membranes (PubMed:18823126). NPC2 binds cholesterol with a 1:1 stoichiometry (PubMed:17018531). Can bind a variety of sterols, including lathosterol, desmosterol and the plant sterols stigmasterol and beta-sitosterol (PubMed:17018531). The secreted form of NCP2 regulates biliary cholesterol secretion via stimulation of ABCG5/ABCG8-mediated cholesterol transport (By similarity)","subcellular_location":"Secreted; Endoplasmic reticulum; Lysosome","url":"https://www.uniprot.org/uniprotkb/P61916/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/NPC2","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"TSR2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/NPC2","total_profiled":1310},"omim":[{"mim_id":"617831","title":"INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55","url":"https://www.omim.org/entry/617831"},{"mim_id":"611759","title":"STARD3 N-TERMINAL-LIKE; STARD3NL","url":"https://www.omim.org/entry/611759"},{"mim_id":"610463","title":"NUS1 DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE SUBUNIT; NUS1","url":"https://www.omim.org/entry/610463"},{"mim_id":"608172","title":"DEHYDRODOLICHYL DIPHOSPHATE SYNTHASE; DHDDS","url":"https://www.omim.org/entry/608172"},{"mim_id":"607625","title":"NIEMANN-PICK DISEASE, TYPE C2; NPC2","url":"https://www.omim.org/entry/607625"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"epididymis","ntpm":15839.4}],"url":"https://www.proteinatlas.org/search/NPC2"},"hgnc":{"alias_symbol":["HE1","NP-C2","EDDM1"],"prev_symbol":[]},"alphafold":{"accession":"P61916","domains":[{"cath_id":"2.60.40.770","chopping":"24-147","consensus_level":"high","plddt":97.871,"start":24,"end":147}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P61916","model_url":"https://alphafold.ebi.ac.uk/files/AF-P61916-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P61916-F1-predicted_aligned_error_v6.png","plddt_mean":92.88},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=NPC2","jax_strain_url":"https://www.jax.org/strain/search?query=NPC2"},"sequence":{"accession":"P61916","fasta_url":"https://rest.uniprot.org/uniprotkb/P61916.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P61916/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P61916"}},"corpus_meta":[{"pmid":"11125141","id":"PMC_11125141","title":"Identification of HE1 as the second gene of Niemann-Pick C disease.","date":"2000","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/11125141","citation_count":680,"is_preprint":false},{"pmid":"18772377","id":"PMC_18772377","title":"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 and lipid bilayers, a step in cholesterol egress from lysosomes.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18772377","citation_count":396,"is_preprint":false},{"pmid":"15071184","id":"PMC_15071184","title":"Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport.","date":"2004","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/15071184","citation_count":289,"is_preprint":false},{"pmid":"15465426","id":"PMC_15465426","title":"Consequences of NPC1 and NPC2 loss of function in mammalian neurons.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15465426","citation_count":224,"is_preprint":false},{"pmid":"12719428","id":"PMC_12719428","title":"NPC1 and NPC2 regulate cellular cholesterol homeostasis through generation of low density lipoprotein cholesterol-derived oxysterols.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12719428","citation_count":176,"is_preprint":false},{"pmid":"17573352","id":"PMC_17573352","title":"Structural basis of sterol binding by NPC2, a lysosomal protein deficient in Niemann-Pick type C2 disease.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17573352","citation_count":176,"is_preprint":false},{"pmid":"19232397","id":"PMC_19232397","title":"Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.","date":"2009","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/19232397","citation_count":165,"is_preprint":false},{"pmid":"10366780","id":"PMC_10366780","title":"A porcine homolog of the major secretory protein of human epididymis, HE1, specifically binds cholesterol.","date":"1999","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/10366780","citation_count":164,"is_preprint":false},{"pmid":"27551080","id":"PMC_27551080","title":"Clues to the mechanism of cholesterol transfer from the structure of NPC1 middle lumenal domain bound to NPC2.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27551080","citation_count":147,"is_preprint":false},{"pmid":"22065762","id":"PMC_22065762","title":"Niemann-Pick type C 1 function requires lumenal domain residues that mediate cholesterol-dependent NPC2 binding.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22065762","citation_count":128,"is_preprint":false},{"pmid":"11567215","id":"PMC_11567215","title":"Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.","date":"2001","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11567215","citation_count":125,"is_preprint":false},{"pmid":"8924505","id":"PMC_8924505","title":"Molecular cloning and characterization of HE1, a major secretory protein of the human epididymis.","date":"1996","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/8924505","citation_count":113,"is_preprint":false},{"pmid":"15465422","id":"PMC_15465422","title":"Structure and function of the NPC2 protein.","date":"2004","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/15465422","citation_count":100,"is_preprint":false},{"pmid":"17018531","id":"PMC_17018531","title":"NPC2, the protein deficient in Niemann-Pick C2 disease, consists of multiple glycoforms that bind a variety of sterols.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17018531","citation_count":96,"is_preprint":false},{"pmid":"24501203","id":"PMC_24501203","title":"All-trans retinoic acid-triggered antimicrobial activity against Mycobacterium tuberculosis is dependent on NPC2.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/24501203","citation_count":90,"is_preprint":false},{"pmid":"12554680","id":"PMC_12554680","title":"Defective endocytic trafficking of NPC1 and NPC2 underlying infantile Niemann-Pick type C disease.","date":"2003","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12554680","citation_count":81,"is_preprint":false},{"pmid":"18823126","id":"PMC_18823126","title":"Regulation of sterol transport between membranes and NPC2.","date":"2008","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18823126","citation_count":77,"is_preprint":false},{"pmid":"22580186","id":"PMC_22580186","title":"Drosophila melanogaster NPC2 proteins bind bacterial cell wall components and may function in immune signal pathways.","date":"2012","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/22580186","citation_count":76,"is_preprint":false},{"pmid":"25339683","id":"PMC_25339683","title":"Acid sphingomyelinase activity is regulated by membrane lipids and facilitates cholesterol transfer by NPC2.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/25339683","citation_count":72,"is_preprint":false},{"pmid":"31580258","id":"PMC_31580258","title":"Intracellular cholesterol trafficking is dependent upon NPC2 interaction with lysobisphosphatidic acid.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31580258","citation_count":66,"is_preprint":false},{"pmid":"20179319","id":"PMC_20179319","title":"Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion.","date":"2010","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/20179319","citation_count":66,"is_preprint":false},{"pmid":"16126423","id":"PMC_16126423","title":"Niemann-Pick C disease: use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families.","date":"2005","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16126423","citation_count":66,"is_preprint":false},{"pmid":"17470133","id":"PMC_17470133","title":"Niemann-Pick C disease: functional characterization of three NPC2 mutations and clinical and molecular update on patients with NPC2.","date":"2007","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17470133","citation_count":52,"is_preprint":false},{"pmid":"15542393","id":"PMC_15542393","title":"Niemann-Pick type C disease: importance of N-glycosylation sites for function and cellular location of the NPC2 protein.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15542393","citation_count":52,"is_preprint":false},{"pmid":"12447927","id":"PMC_12447927","title":"Frontal lobe atrophy due to a mutation in the cholesterol binding protein HE1/NPC2.","date":"2002","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/12447927","citation_count":51,"is_preprint":false},{"pmid":"16374838","id":"PMC_16374838","title":"NPC2 is expressed in human and murine liver and secreted into bile: potential implications for body cholesterol homeostasis.","date":"2006","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/16374838","citation_count":51,"is_preprint":false},{"pmid":"15896196","id":"PMC_15896196","title":"NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein.","date":"2005","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15896196","citation_count":50,"is_preprint":false},{"pmid":"21315718","id":"PMC_21315718","title":"NPC2 regulates biliary cholesterol secretion via stimulation of ABCG5/G8-mediated cholesterol transport.","date":"2011","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/21315718","citation_count":46,"is_preprint":false},{"pmid":"28658628","id":"PMC_28658628","title":"The GARP Complex Is Involved in Intracellular Cholesterol Transport via Targeting NPC2 to Lysosomes.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28658628","citation_count":44,"is_preprint":false},{"pmid":"11571306","id":"PMC_11571306","title":"Cholesterol overload promotes morphogenesis of a Niemann-Pick C (NPC)-like compartment independent of inhibition of NPC1 or HE1/NPC2 function.","date":"2001","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11571306","citation_count":42,"is_preprint":false},{"pmid":"15355983","id":"PMC_15355983","title":"Secretion of sterols and the NPC2 protein from primary astrocytes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15355983","citation_count":41,"is_preprint":false},{"pmid":"28082351","id":"PMC_28082351","title":"FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts.","date":"2017","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/28082351","citation_count":41,"is_preprint":false},{"pmid":"27826286","id":"PMC_27826286","title":"Transcriptomic Biomarkers for Tuberculosis: Evaluation of DOCK9. EPHA4, and NPC2 mRNA Expression in Peripheral Blood.","date":"2016","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/27826286","citation_count":40,"is_preprint":false},{"pmid":"31159921","id":"PMC_31159921","title":"Sterol transfer by atypical cholesterol-binding NPC2 proteins in coral-algal symbiosis.","date":"2019","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/31159921","citation_count":38,"is_preprint":false},{"pmid":"21214551","id":"PMC_21214551","title":"Regulation of the NPC2 protein-mediated cholesterol trafficking by membrane lipids.","date":"2011","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21214551","citation_count":38,"is_preprint":false},{"pmid":"19252935","id":"PMC_19252935","title":"Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations.","date":"2009","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/19252935","citation_count":37,"is_preprint":false},{"pmid":"26846330","id":"PMC_26846330","title":"Structure of glycosylated NPC1 luminal domain C reveals insights into NPC2 and Ebola virus interactions.","date":"2016","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/26846330","citation_count":37,"is_preprint":false},{"pmid":"23666609","id":"PMC_23666609","title":"Involvement of cathepsins B and L in inflammation and cholesterol trafficking protein NPC2 secretion in macrophages.","date":"2013","source":"Obesity (Silver Spring, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23666609","citation_count":36,"is_preprint":false},{"pmid":"27940359","id":"PMC_27940359","title":"The new obesity-associated protein, neuronal growth regulator 1 (NEGR1), is implicated in Niemann-Pick disease Type C (NPC2)-mediated cholesterol trafficking.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27940359","citation_count":36,"is_preprint":false},{"pmid":"24915861","id":"PMC_24915861","title":"Diagnosis of Niemann-Pick disease type C with 7-ketocholesterol screening followed by NPC1/NPC2 gene mutation confirmation in Chinese patients.","date":"2014","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/24915861","citation_count":35,"is_preprint":false},{"pmid":"21740003","id":"PMC_21740003","title":"Sterol transfer between cyclodextrin and membranes: similar but not identical mechanism to NPC2-mediated cholesterol transfer.","date":"2011","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21740003","citation_count":35,"is_preprint":false},{"pmid":"23843985","id":"PMC_23843985","title":"Pulmonary abnormalities in animal models due to Niemann-Pick type C1 (NPC1) or C2 (NPC2) disease.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23843985","citation_count":34,"is_preprint":false},{"pmid":"16772431","id":"PMC_16772431","title":"HE1/NPC2 status in human reproductive tract and ejaculated spermatozoa: consequence of vasectomy.","date":"2006","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/16772431","citation_count":31,"is_preprint":false},{"pmid":"31843136","id":"PMC_31843136","title":"The characteristics and biological significance of NPC2: Mutation and disease.","date":"2019","source":"Mutation research. Reviews in mutation research","url":"https://pubmed.ncbi.nlm.nih.gov/31843136","citation_count":29,"is_preprint":false},{"pmid":"17880278","id":"PMC_17880278","title":"Do mammalian NPC1 and NPC2 play a role in intestinal cholesterol absorption?","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17880278","citation_count":29,"is_preprint":false},{"pmid":"31098815","id":"PMC_31098815","title":"Insights into the Molecular Mechanisms of Cholesterol Binding to the NPC1 and NPC2 Proteins.","date":"2019","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/31098815","citation_count":27,"is_preprint":false},{"pmid":"26183450","id":"PMC_26183450","title":"The cholesterol-binding protein NPC2 restrains recruitment of stromal macrophage-lineage cells to early-stage lung tumours.","date":"2015","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26183450","citation_count":27,"is_preprint":false},{"pmid":"24709320","id":"PMC_24709320","title":"Spermatozoa from mice deficient in Niemann-Pick disease type C2 (NPC2) protein have defective cholesterol content and reduced in vitro fertilising ability.","date":"2014","source":"Reproduction, fertility, and development","url":"https://pubmed.ncbi.nlm.nih.gov/24709320","citation_count":27,"is_preprint":false},{"pmid":"24001314","id":"PMC_24001314","title":"Computational studies of the cholesterol transport between NPC2 and the N-terminal domain of NPC1 (NPC1(NTD)).","date":"2013","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24001314","citation_count":27,"is_preprint":false},{"pmid":"28544363","id":"PMC_28544363","title":"Expression patterns of sterol transporters NPC1 and NPC2 in the cnidarian-dinoflagellate symbiosis.","date":"2017","source":"Cellular microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/28544363","citation_count":26,"is_preprint":false},{"pmid":"28270911","id":"PMC_28270911","title":"Relationship between HSP90a, NPC2 and L-PGDS proteins to boar semen freezability.","date":"2017","source":"Journal of animal science and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/28270911","citation_count":25,"is_preprint":false},{"pmid":"15381285","id":"PMC_15381285","title":"Neuronal localization and association of Niemann Pick C2 protein (HE1/NPC2) with the postsynaptic density.","date":"2004","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15381285","citation_count":24,"is_preprint":false},{"pmid":"14662784","id":"PMC_14662784","title":"Vasectomy influences expression of HE1 but not HE2 and HE5 genes in human epididymis.","date":"2004","source":"Journal of andrology","url":"https://pubmed.ncbi.nlm.nih.gov/14662784","citation_count":23,"is_preprint":false},{"pmid":"29084218","id":"PMC_29084218","title":"Concerted regulation of npc2 binding to endosomal/lysosomal membranes by bis(monoacylglycero)phosphate and sphingomyelin.","date":"2017","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/29084218","citation_count":23,"is_preprint":false},{"pmid":"15937921","id":"PMC_15937921","title":"Niemann-Pick type C disease: subcellular location and functional characterization of NPC2 proteins with naturally occurring missense mutations.","date":"2005","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/15937921","citation_count":23,"is_preprint":false},{"pmid":"28095804","id":"PMC_28095804","title":"Pulmonary manifestations in Niemann-Pick type C disease with mutations in NPC2 gene: case report and review of literature.","date":"2017","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28095804","citation_count":21,"is_preprint":false},{"pmid":"26995145","id":"PMC_26995145","title":"The NPC2 protein: A novel dog allergen.","date":"2016","source":"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26995145","citation_count":18,"is_preprint":false},{"pmid":"29655638","id":"PMC_29655638","title":"Attenuation of the Niemann-Pick type C2 disease phenotype by intracisternal administration of an AAVrh.10 vector expressing Npc2.","date":"2018","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29655638","citation_count":18,"is_preprint":false},{"pmid":"30091016","id":"PMC_30091016","title":"The non-canonical NF-κB pathway promotes NPC2 expression and regulates intracellular cholesterol trafficking.","date":"2018","source":"Science China. Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30091016","citation_count":16,"is_preprint":false},{"pmid":"19883728","id":"PMC_19883728","title":"Female infertility due to anovulation and defective steroidogenesis in NPC2 deficient mice.","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19883728","citation_count":16,"is_preprint":false},{"pmid":"34445279","id":"PMC_34445279","title":"Secretory NPC2 Protein-Mediated Free Cholesterol Levels Were Correlated with the Sorafenib Response in Hepatocellular Carcinoma.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/34445279","citation_count":15,"is_preprint":false},{"pmid":"35653304","id":"PMC_35653304","title":"BORC-ARL8-HOPS ensemble is required for lysosomal cholesterol egress through NPC2.","date":"2022","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/35653304","citation_count":14,"is_preprint":false},{"pmid":"33986646","id":"PMC_33986646","title":"npc2-Deficient Zebrafish Reproduce Neurological and Inflammatory Symptoms of Niemann-Pick Type C Disease.","date":"2021","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33986646","citation_count":14,"is_preprint":false},{"pmid":"31711697","id":"PMC_31711697","title":"Relative content of Niemann-Pick C2 protein (NPC2) in seminal plasma, but not that of spermadhesin AQN-1, is related to boar sperm cryotolerance.","date":"2019","source":"Theriogenology","url":"https://pubmed.ncbi.nlm.nih.gov/31711697","citation_count":14,"is_preprint":false},{"pmid":"23791309","id":"PMC_23791309","title":"Identification of mutation in NPC2 by exome sequencing results in diagnosis of Niemann-Pick disease type C.","date":"2013","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23791309","citation_count":14,"is_preprint":false},{"pmid":"25251378","id":"PMC_25251378","title":"Niemann-Pick type C disease: a QM/MM study of conformational changes in cholesterol in the NPC1(NTD) and NPC2 binding pockets.","date":"2014","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25251378","citation_count":14,"is_preprint":false},{"pmid":"38136141","id":"PMC_38136141","title":"Niemann-Pick Disease Type C (NPDC) by Mutation of NPC1 and NPC2: Aberrant Lysosomal Cholesterol Trafficking and Oxidative Stress.","date":"2023","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/38136141","citation_count":13,"is_preprint":false},{"pmid":"34420959","id":"PMC_34420959","title":"Niemann-Pick Type C 1 (NPC1) and NPC2 Gene Variability in Demented Patients with Evidence of Brain Amyloid Deposition.","date":"2021","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/34420959","citation_count":13,"is_preprint":false},{"pmid":"33191681","id":"PMC_33191681","title":"Cat-NPC2, a Newly Identified Allergen, With High Cross-Reactivity to Can f 7.","date":"2021","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/33191681","citation_count":13,"is_preprint":false},{"pmid":"35272007","id":"PMC_35272007","title":"Retinoic acid restores the levels of cellular cholesterol in Leishmania donovani infected macrophages by increasing npc1 and npc2 expressions.","date":"2022","source":"Biochimie","url":"https://pubmed.ncbi.nlm.nih.gov/35272007","citation_count":13,"is_preprint":false},{"pmid":"19664597","id":"PMC_19664597","title":"Identification of NPC2 protein as interaction molecule with C2 domain of human Nedd4L.","date":"2009","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/19664597","citation_count":10,"is_preprint":false},{"pmid":"35926690","id":"PMC_35926690","title":"Effects of Niemann-Pick type C2 (NPC2) gene transcripts silencing on behavior of Varroa destructor and molecular changes in the putative olfactory gene networks.","date":"2022","source":"Insect biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/35926690","citation_count":10,"is_preprint":false},{"pmid":"30181526","id":"PMC_30181526","title":"Simulations of NPC1(NTD):NPC2 Protein Complex Reveal Cholesterol Transfer Pathways.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30181526","citation_count":9,"is_preprint":false},{"pmid":"15808435","id":"PMC_15808435","title":"[Fatal neonatal respiratory distress in Niemann-Pick C2 and prenatal diagnosis with mutations in gene HE1/NPC2].","date":"2005","source":"Archives de pediatrie : organe officiel de la Societe francaise de pediatrie","url":"https://pubmed.ncbi.nlm.nih.gov/15808435","citation_count":9,"is_preprint":false},{"pmid":"19746448","id":"PMC_19746448","title":"Physiological and coordinate downregulation of the NPC1 and NPC2 genes are associated with the sequestration of LDL-derived cholesterol within endocytic compartments.","date":"2009","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19746448","citation_count":9,"is_preprint":false},{"pmid":"25396745","id":"PMC_25396745","title":"Characterization of a spontaneous novel mutation in the NPC2 gene in a cat affected by Niemann Pick type C disease.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25396745","citation_count":9,"is_preprint":false},{"pmid":"34685683","id":"PMC_34685683","title":"Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685683","citation_count":8,"is_preprint":false},{"pmid":"25338779","id":"PMC_25338779","title":"Effect of the replacement of aspartic acid/glutamic acid residues with asparagine/glutamine residues in RNase He1 from Hericium erinaceus on inhibition of human leukemia cell line proliferation.","date":"2014","source":"Bioscience, biotechnology, and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25338779","citation_count":7,"is_preprint":false},{"pmid":"17956226","id":"PMC_17956226","title":"A role for NPC1 and NPC2 in intestinal cholesterol absorption--the hypothesis gutted.","date":"2007","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/17956226","citation_count":7,"is_preprint":false},{"pmid":"39747180","id":"PMC_39747180","title":"Deficiency in NPC2 results in disruption of mitochondria-late endosome/lysosomes contact sites and endo-lysosomal lipid dyshomeostasis.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/39747180","citation_count":6,"is_preprint":false},{"pmid":"37454976","id":"PMC_37454976","title":"The Npc2Gt(LST105)BygNya mouse signifies pathological changes comparable to human Niemann-Pick type C2 disease.","date":"2023","source":"Molecular and cellular neurosciences","url":"https://pubmed.ncbi.nlm.nih.gov/37454976","citation_count":6,"is_preprint":false},{"pmid":"37056065","id":"PMC_37056065","title":"Exploration of NPC2 as a Potential Biomarker for Immunotherapy Using RNA-seq and Protein Data - A New Hypothesis.","date":"2023","source":"Endocrine, metabolic & immune disorders drug targets","url":"https://pubmed.ncbi.nlm.nih.gov/37056065","citation_count":6,"is_preprint":false},{"pmid":"38509982","id":"PMC_38509982","title":"Low expression of lysosome-related genes KCNE1, NPC2, and SFTPD promote cancer cell proliferation and tumor associated M2 macrophage polarization in lung adenocarcinoma.","date":"2024","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/38509982","citation_count":5,"is_preprint":false},{"pmid":"37890669","id":"PMC_37890669","title":"TMEM241 is a UDP-N-acetylglucosamine transporter required for M6P modification of NPC2 and cholesterol transport.","date":"2023","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/37890669","citation_count":5,"is_preprint":false},{"pmid":"33990640","id":"PMC_33990640","title":"Identification and Classification of Rare Variants in NPC1 and NPC2 in Quebec.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/33990640","citation_count":4,"is_preprint":false},{"pmid":"19723490","id":"PMC_19723490","title":"Getting a \"Hold\" on NPC2.","date":"2009","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/19723490","citation_count":4,"is_preprint":false},{"pmid":"33924575","id":"PMC_33924575","title":"Pathophysiological In Vitro Profile of Neuronal Differentiated Cells Derived from Niemann-Pick Disease Type C2 Patient-Specific iPSCs Carrying the NPC2 Mutations c.58G>T/c.140G>T.","date":"2021","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/33924575","citation_count":4,"is_preprint":false},{"pmid":"38109854","id":"PMC_38109854","title":"Focusing on the Abnormal Events of NPC1, NPC2, and NPC1L1 in Pan-Cancer and Further Constructing LUAD and KICH Prediction Models.","date":"2023","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/38109854","citation_count":3,"is_preprint":false},{"pmid":"39798440","id":"PMC_39798440","title":"NPC2, a seminal plasma protein with membrane cholesterol-binding ability, influences the cryotolerance and functionality of spermatozoa from Chino Santandereano bulls.","date":"2024","source":"Animal reproduction science","url":"https://pubmed.ncbi.nlm.nih.gov/39798440","citation_count":3,"is_preprint":false},{"pmid":"39605369","id":"PMC_39605369","title":"SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by disrupting VPS39-regulated NPC2 trafficking and BMP metabolism.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39605369","citation_count":3,"is_preprint":false},{"pmid":"37458497","id":"PMC_37458497","title":"Novel Mutation in the Feline NPC2 Gene in Cats with Niemann-Pick Disease.","date":"2023","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/37458497","citation_count":2,"is_preprint":false},{"pmid":"33532030","id":"PMC_33532030","title":"NPC2 expression in thyroid tumors and its possible diagnostic utility.","date":"2021","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/33532030","citation_count":2,"is_preprint":false},{"pmid":"40149401","id":"PMC_40149401","title":"Genome-Wide Identification, Gene Duplication, and Expression Pattern of NPC2 Gene Family in Parnassius glacialis.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40149401","citation_count":2,"is_preprint":false},{"pmid":"40681956","id":"PMC_40681956","title":"ALKBH5-mediated NPC2 mRNA m6A demethylation promotes resistance to oxaliplatin in colorectal cancer.","date":"2025","source":"Functional & integrative genomics","url":"https://pubmed.ncbi.nlm.nih.gov/40681956","citation_count":2,"is_preprint":false},{"pmid":"20001954","id":"PMC_20001954","title":"Proteomic identification and characterization of secreted N-glycosylated NPC2 following cross-linking of the high-affinity receptor for IgE on mast cells.","date":"2010","source":"Cell biology international","url":"https://pubmed.ncbi.nlm.nih.gov/20001954","citation_count":2,"is_preprint":false},{"pmid":"32556727","id":"PMC_32556727","title":"Existence and distribution of Niemann-Pick type 2C (NPC2) in prawn reproductive tract and its putative role as a cholesterol modulator during sperm transit in the vas deferens.","date":"2020","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/32556727","citation_count":2,"is_preprint":false},{"pmid":"40785403","id":"PMC_40785403","title":"Interaction between expression of CD23 on B-lymphocytes and level of specific IgE against molecular components of NPC2 family, lipocalins, uteroglobins, and molecular components of molds and yeast.","date":"2025","source":"Journal of immunotoxicology","url":"https://pubmed.ncbi.nlm.nih.gov/40785403","citation_count":1,"is_preprint":false},{"pmid":"25366489","id":"PMC_25366489","title":"Mutagenesis of the novel Hericium erinaceus ribonuclease, RNase He1, reveals critical responsible residues for enzyme stability and activity.","date":"2014","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/25366489","citation_count":1,"is_preprint":false},{"pmid":"31787719","id":"PMC_31787719","title":"X-Ray Crystallographic Structure of Hericium erinaceus Ribonuclease, RNase He1 in Complex with Zinc.","date":"2019","source":"Biological & pharmaceutical bulletin","url":"https://pubmed.ncbi.nlm.nih.gov/31787719","citation_count":1,"is_preprint":false},{"pmid":"41850403","id":"PMC_41850403","title":"Transport of sphingolipids by yeast Npc2 supports phase separation of the vacuole membrane.","date":"2026","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/41850403","citation_count":1,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":50614,"output_tokens":7734,"usd":0.133926,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":17404,"output_tokens":7171,"usd":0.133148,"stage2_stop_reason":"end_turn"},"total_usd":0.267074,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"HE1/NPC2 is a ubiquitously expressed lysosomal protein whose deficiency causes Niemann-Pick type C2 disease; exogenous recombinant NPC2 protein ameliorated lysosomal accumulation of LDL-derived cholesterol in NPC2-deficient fibroblasts, establishing its direct role in cholesterol egress from lysosomes.\",\n      \"method\": \"Fibroblast complementation assay with recombinant protein, mutation analysis, Western blot\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — loss-of-function patient fibroblasts plus protein rescue experiment, replicated across multiple patient samples, foundational disease gene identification\",\n      \"pmids\": [\"11125141\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The porcine NPC2 homolog (HE1 homolog) specifically binds cholesterol with high affinity (Kd = 2.3 µM) in a 1:1 stoichiometry, establishing NPC2 as a cholesterol-binding protein.\",\n      \"method\": \"In vitro cholesterol binding assay with purified protein, stoichiometry determination\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct in vitro biochemical binding assay with purified protein; replicated in subsequent human studies\",\n      \"pmids\": [\"10366780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Crystal structure of bovine NPC2 bound to cholesterol-3-O-sulfate revealed that the sterol binds in a deep hydrophobic pocket between two β-sheets, with only the sulfate substituent exposed to solvent; two aromatic residues at the tunnel entrance are repositioned upon sterol binding and are essential for NPC2 function.\",\n      \"method\": \"X-ray crystallography (apo and sterol-bound forms), structural analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure at atomic resolution with both apo and bound forms, functionally validated by mutagenesis data from complementary studies\",\n      \"pmids\": [\"17573352\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NPC2 facilitates bidirectional transfer of cholesterol between NPC1 N-terminal domain (NTD) and phosphatidylcholine liposomes; NPC2 accelerates cholesterol transfer between NPC1(NTD) and liposomes >100-fold; the naturally occurring P120S mutant of NPC2 fails to bind cholesterol and fails to stimulate this transfer, establishing NPC2 as an essential intermediary in lysosomal cholesterol handoff to NPC1.\",\n      \"method\": \"In vitro cholesterol transfer assay with [3H]cholesterol, liposomes, and purified recombinant proteins; mutagenesis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — reconstituted in vitro transfer assay with mutagenesis validation, rigorous quantitative measurements\",\n      \"pmids\": [\"18772377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Genetic epistasis analysis using NPC1;NPC2 double-mutant mice showed that NPC1 and NPC2 single mutants and double mutants have identical or similar phenotypes in disease onset, pathology, neuronal storage, and lipid biochemistry, providing genetic evidence that NPC1 and NPC2 function in concert (non-redundantly) to facilitate lysosomal lipid egress.\",\n      \"method\": \"Double-mutant mouse genetics, biochemical lipid analysis, histopathology\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis in mouse model with multiple phenotypic readouts across labs\",\n      \"pmids\": [\"15071184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The second lumenal domain (MLD) of NPC1 binds directly to NPC2, and this interaction is only detected at acidic pH and requires cholesterol to be bound to NPC2, supporting directional cholesterol transfer from NPC2 to NPC1's N-terminal domain. Disease-causing mutations in NPC1 domain 2 decrease NPC2 binding.\",\n      \"method\": \"Surface plasmon resonance, affinity chromatography, engineered soluble NPC1 domain constructs\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — SPR binding assay plus affinity chromatography, pH-dependence and cholesterol-dependence validated, disease mutation analysis included\",\n      \"pmids\": [\"22065762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Crystal structure at 2.4-Å resolution of the human NPC1 middle lumenal domain (MLD) bound to NPC2 carrying cholesterol-3-O-sulfate revealed that NPC1-MLD uses two protruding loops to bind NPC2 (analogous to Ebola virus glycoprotein interaction). Docking onto full-length NPC1 reveals a direct cholesterol transfer tunnel between NPC2 and NPC1 NTD binding pockets, supporting the 'hydrophobic hand-off' model.\",\n      \"method\": \"X-ray crystallography (2.4-Å), structural docking analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — atomic-resolution crystal structure of the protein complex with ligand, structural docking analysis\",\n      \"pmids\": [\"27551080\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NPC2 consists of multiple N-glycoforms; mass spectrometry revealed that Asn-19 is not glycosylated, Asn-39 carries Endo H-sensitive oligosaccharide, and Asn-116 is variably utilized. NPC2 binds a range of cholesterol-related molecules (cholesterol precursors, plant sterols, some oxysterols, cholesterol sulfate) but not glycolipids, phospholipids, or fatty acids, and forms an equimolar complex with dehydroergosterol.\",\n      \"method\": \"Mass spectrometry, cation-exchange chromatography-based binding assay, endoglycosidase treatment, fluorescence binding assay\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biochemical methods in single study (MS, chromatography-based binding, fluorescence)\",\n      \"pmids\": [\"17018531\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"N-glycosylation at Asn-58 (but not Asn-135) is required for proper lysosomal targeting of NPC2; only the oligosaccharide at Asn-58 is responsible for targeting to lysosomes and is crucial for NPC2 function in restoring normal cholesterol trafficking in NPC2-deficient cells.\",\n      \"method\": \"Site-directed mutagenesis of glycosylation sites, immunocytofluorescence microscopy in NPC2-/- fibroblasts, cholesterol trafficking complementation assay\",\n      \"journal\": \"Molecular genetics and metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mutagenesis combined with functional complementation and subcellular localization in disease cell model\",\n      \"pmids\": [\"15542393\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"NPC2 transfers cholesterol from membranes to the protein and between membranes via a mechanism involving direct protein-membrane interaction (confirmed by FTIR spectroscopy and tryptophan spectral shifts); the lysosomal phospholipid lyso-bisphosphatidic acid (LBPA) greatly enhances NPC2-mediated cholesterol transfer rates by up to 2 orders of magnitude.\",\n      \"method\": \"Fluorescence spectroscopy cholesterol transfer assay, FTIR spectroscopy, tryptophan fluorescence spectroscopy\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal biophysical methods in single study establishing mechanism and LBPA stimulation\",\n      \"pmids\": [\"18823126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"NPC2 interacts directly with LBPA, and the NPC2 hydrophobic knob domain is the site of this interaction; LBPA enrichment in NPC2-deficient human cells is entirely ineffective at clearing cholesterol (unlike in NPC1-deficient cells), establishing an obligate functional interaction between NPC2 and LBPA in intracellular cholesterol trafficking.\",\n      \"method\": \"Direct binding assay (LBPA-NPC2 interaction), lipid enrichment of patient fibroblasts, domain mapping mutagenesis\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct binding assay plus functional complementation in patient cells plus domain-level mapping\",\n      \"pmids\": [\"31580258\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"NPC2 mediates cholesterol transfer between liposomes and stimulates membrane fusion; BMP (bis(monoacylglycero)phosphate) greatly stimulates NPC2-mediated cholesterol transfer, while sphingomyelin inhibits it; ceramide, produced from sphingomyelin hydrolysis, enhances transfer. NPC2 shows specificity for cholesterol over other lipids including ceramide, GM3, phosphatidylethanolamine, and phosphatidylserine.\",\n      \"method\": \"In vitro liposome cholesterol transfer assay with fluorescent/biotinylated vesicles, membrane fusion assay\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — quantitative in vitro reconstitution with defined lipid compositions, specificity tested for multiple lipid species\",\n      \"pmids\": [\"20179319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Acid sphingomyelinase (ASM)-mediated hydrolysis of sphingomyelin to ceramide in late endosomal membranes is required for physiological NPC2-mediated cholesterol transfer; ASM stimulates NPC2-dependent cholesterol export from the late endosomal compartment.\",\n      \"method\": \"Liposomal cholesterol transfer assay with ASM preincubation, lipid composition manipulation\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro liposome assay, single lab, mechanistic link established but not independently replicated\",\n      \"pmids\": [\"25339683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The GARP complex (containing VPS53) is required for CI-MPR-dependent sorting/trafficking of NPC2 to lysosomes; depletion of GARP subunits impaired NPC2 lysosomal delivery, blocked CI-MPR retrieval to the trans-Golgi network, and caused cholesterol accumulation. Vps54 mutant mice displayed reduced NPC2 protein levels and increased cholesterol accumulation.\",\n      \"method\": \"Genome-wide CRISPR/amphotericin B selection screen, siRNA knockdown, whole-transcriptome sequencing, mouse genetics\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased genetic screen plus functional validation in cells and mouse model with defined mechanistic pathway\",\n      \"pmids\": [\"28658628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"NPC1 governs the endocytic transport of NPC2: NPC1 mutations cause NPC2 to accumulate in and become upregulated in cholesterol-storing late endocytic organelles; a greater proportion of NPC2 becomes membrane-associated in NPC1 mutant late endosomes compared to wild-type.\",\n      \"method\": \"Subcellular fractionation of mouse liver late endosomes by magnetic chromatography, Western blotting, immunofluorescence\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — fractionation and localization in NPC1 mutant cells, single lab\",\n      \"pmids\": [\"12554680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"NPC2 is present in an incompletely deglycosylated form in NPC1 late endosomes by a mechanism specific to NPC2 (secreted NPC2 from NPC1 cells is normal); a greater proportion of NPC2 partitions with detergent-insoluble late endosomal internal membrane domains in NPC1 vesicles.\",\n      \"method\": \"Magnetic chromatography isolation of late endosomes, Endo H/PNGase F treatment, Western blotting, detergent fractionation\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — biochemical fractionation with specific enzymatic controls, single lab\",\n      \"pmids\": [\"15896196\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NPC2/HE1 is localized predominantly in neurons (especially pyramidal cells of cerebral cortex, amygdala, and Purkinje cells) and is present in the cytosol of dendrites and on postsynaptic densities (PSD) of neurons, as confirmed by electron microscopic immunocytochemistry and Western blot of PSD-enriched fractions.\",\n      \"method\": \"Immunocytochemistry, electron microscopic immunocytochemistry, subcellular fractionation, Western blotting\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct electron microscopic localization and fractionation, single lab, functional consequence not directly tested\",\n      \"pmids\": [\"15381285\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"NPC2 is expressed in liver and secreted into bile and plasma; hepatic NPC2 protein expression is dramatically increased in NPC1-deficient mice; biliary NPC2 is exclusively found in the cholesterol pro-nucleating ConA-binding fraction of human bile.\",\n      \"method\": \"Western blotting of bile and plasma fractions, ConA-binding fractionation, NPC1 knockout mouse analysis\",\n      \"journal\": \"Hepatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — protein fractionation and mouse genetics, single lab, functional role in bile inferred\",\n      \"pmids\": [\"16374838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Secreted NPC2 stimulates ABCG5/G8-mediated biliary cholesterol efflux but not NPC1L1-mediated cholesterol uptake; hepatic NPC2 overexpression failed to increase biliary cholesterol in ABCG5/G8-null mice, demonstrating that NPC2 requires ABCG5/G8 to stimulate biliary cholesterol secretion. This function was shown to be independent of NPC2's lysosomal cholesterol trafficking function.\",\n      \"method\": \"Adenovirus-mediated hepatic knockdown/overexpression in mice, biliary lipid analysis, in vitro transporter activity assay, ABCG5/G8-null mouse experiment\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse genetics with defined null background plus in vitro mechanistic confirmation, multiple complementary approaches\",\n      \"pmids\": [\"21315718\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Atomistic MD simulations identified two competitive membrane binding orientations of NPC2: a 'Prone' mode placing the cholesterol binding pocket in contact with the membrane (associated with cholesterol uptake/release, requires BMP specifically) and a 'Supine' mode with the pocket away from membrane. BMP is specifically required for strong Prone mode binding; sphingomyelin counteracts BMP by hindering Prone mode.\",\n      \"method\": \"Atomistic molecular dynamics simulations, free energy calculations\",\n      \"journal\": \"PLoS computational biology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — computational only, no experimental validation in same study, consistent with experimental LBPA/BMP data\",\n      \"pmids\": [\"29084218\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"The non-canonical NF-κB pathway (NF-κB2) directly activates NPC2 transcription by binding its promoter; disruption of NF-κB2 or other non-canonical pathway members suppresses NPC2 expression and causes intracellular cholesterol accumulation; LTβR or BaffR stimulation upregulates NPC2 mRNA and protein.\",\n      \"method\": \"RNAi knockdown, promoter binding assay (ChIP), qPCR, cholesterol accumulation assay, NF-κB2-deficient zebrafish embryos and mice\",\n      \"journal\": \"Science China. Life sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct promoter binding plus loss-of-function in cells and in vivo models, single lab\",\n      \"pmids\": [\"30091016\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"TMEM241, a Golgi-localized UDP-GlcNAc transporter, is required for mannose-6-phosphate (M6P) modification of NPC2; ablation of TMEM241 impairs M6P-dependent lysosomal targeting of NPC2, causing cholesterol accumulation in lysosomes. Tmem241-deficient mice display cholesterol accumulation in pulmonary cells.\",\n      \"method\": \"Genome-wide CRISPR-Cas9 KO screen (amphotericin B-based), TMEM241 KO cell characterization, M6P modification assay, mouse knockout\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased genetic screen plus mechanistic validation (M6P modification assay), in vivo mouse model confirmation\",\n      \"pmids\": [\"37890669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The BORC-ARL8-HOPS ensemble is required for CI-MPR-dependent trafficking of NPC2 to lysosomes; depletion of BORC, ARL8, or HOPS decreases NPC2 lysosomal association, increases NPC2 secretion, increases lysosomal degradation of CI-MPR, and impairs cholesterol egress—without altering NPC1 localization.\",\n      \"method\": \"siRNA knockdown, filipin staining, NPC2 localization by immunofluorescence, CI-MPR trafficking assay, cholesterol esterification assay\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple knockdown targets tested, defined pathway placement, single lab\",\n      \"pmids\": [\"35653304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NPC2 is identified as a binding partner of the C2 domain of human Nedd4L (E3 ubiquitin ligase); NPC2 is expressed along the aldosterone-sensitive distal nephron co-localizing with Nedd4L, and NPC2 transcription/activation is regulated by sodium intake in a salt-sensitive hypertension model, suggesting NPC2 may regulate sodium reabsorption by interacting with the ENaC-Nedd4L system.\",\n      \"method\": \"Yeast two-hybrid screening, co-localization immunohistochemistry, Dahl rat salt-sensitive model\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — yeast two-hybrid binding (not confirmed by reciprocal Co-IP), functional consequence inferred from expression data, single lab\",\n      \"pmids\": [\"19664597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"ATRA-triggered antimicrobial activity against M. tuberculosis requires NPC2 expression; NPC2 knockdown abolishes ATRA-induced decrease in total cellular cholesterol and increase in lysosomal acidification, and ablates ATRA-induced antimicrobial activity against M. tuberculosis.\",\n      \"method\": \"siRNA knockdown, cholesterol quantification, lysosomal acidification assay, intracellular M. tuberculosis killing assay\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function with defined functional readouts, single lab, mechanism beyond cholesterol regulation not fully defined\",\n      \"pmids\": [\"24501203\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"NPC2 secreted from premalignant lung tumour cells is taken up by immature macrophage-lineage cells (IMCs) where it suppresses secretion of CCL6 (at least partly by facilitating its lysosomal degradation), thereby restraining CCR1-dependent IMC recruitment to the tumour microenvironment.\",\n      \"method\": \"NPC2 knockout/overexpression in mouse lung tumor model, ex vivo cell secretion assay, CCL6 measurement, IMC recruitment assay in vivo\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — combined in vivo and ex vivo experiments with defined mechanistic readouts, single lab\",\n      \"pmids\": [\"26183450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"NPC2-deficient female mice exhibit anovulation, abnormal estrous cycles, and infertility with reduced serum estradiol and accumulated ovarian cholesterol; NPC2 localizes to theca and luteal cells, establishing a role for NPC2 in ovarian cholesterol export for steroid synthesis.\",\n      \"method\": \"NPC2 knockout mouse model, immunohistochemistry, hormone measurements, filipin staining, superovulation experiments\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function mouse model with defined endocrine phenotype and localization, single lab\",\n      \"pmids\": [\"19883728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Epididymal spermatozoa from NPC2-/- mice have reduced cholesterol content and show defective tyrosine phosphorylation patterns during capacitation and reduced in vitro fertilization ability, establishing NPC2 as a regulator of sperm cholesterol content during epididymal maturation required for fertility.\",\n      \"method\": \"NPC2 knockout mouse model, biochemical cholesterol quantification, flow cytometry, Western blot for tyrosine phosphorylation, in vitro fertilization assay\",\n      \"journal\": \"Reproduction, fertility, and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — loss-of-function knockout with multiple defined functional readouts, single lab\",\n      \"pmids\": [\"24709320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NEGR1 interacts with NPC2 and increases its protein stability; ectopic NEGR1 expression relieves abnormal cholesterol accumulation in endosomal compartments; NEGR1-deficient mouse embryonic fibroblasts exhibit increased cholesterol levels and triglyceride contents.\",\n      \"method\": \"Co-immunoprecipitation, cholesterol accumulation assay (filipin staining), NEGR1 knockout MEFs\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single Co-IP plus functional assay, single lab, mechanism of stability regulation not fully defined\",\n      \"pmids\": [\"27940359\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"NPC2/HE1 secretion from astrocytes is not inhibited by loss of NPC1 function; the majority of sterols secreted from astrocytes are not co-secreted with NPC2 protein, as shown by size-exclusion chromatography with electron microscopy demonstrating separate particles.\",\n      \"method\": \"Size-exclusion chromatography, electron microscopy, Western blot of astrocyte conditioned medium from NPC1-/- and wild-type cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct separation and visualization by orthogonal methods, NPC1-/- mouse astrocytes\",\n      \"pmids\": [\"15355983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"SARS-CoV-2 ORF3a blocks lysosomal cholesterol egress by binding HOPS subunit VPS39, which traps CI-MPR and retromer in endosomes/lysosomes, impairing NPC2 trafficking to lysosomes; additionally, ORF3a reduces BMP levels by decreasing lysosome-mitochondrion membrane contact sites in a VPS39-dependent manner, identifying VPS39 as a regulator of NPC2 trafficking.\",\n      \"method\": \"Co-immunoprecipitation (ORF3a-VPS39), retromer/CI-MPR localization, NPC2 trafficking assay, lipidomics, proteomics, mitochondria-lysosome contact site quantification, VPS39/retromer deletion experiments\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods, preprint not yet peer-reviewed, mechanistic detail well-supported within the study\",\n      \"pmids\": [\"39605369\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"NPC2 deficiency results in reduced mitochondria-late endosome/lysosome contact sites, accumulation of glucosylsphingosine, glucosylceramides, sphingosine, and sphingomyelins in lysosomes, and swollen lipid-dense acidic compartments—without overt oxidative stress changes.\",\n      \"method\": \"NPC2-/- HEK cell model, mass spectrometry lipidomics, contact site quantification by fluorescence microscopy, organelle morphology analysis\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — multiple orthogonal methods (lipidomics, imaging) in defined KO model, single lab, preprint/recent publication\",\n      \"pmids\": [\"39747180\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"NPC2 is a small soluble lysosomal glycoprotein that binds cholesterol in a deep hydrophobic pocket (crystal structure resolved) and functions as the primary intraluminal cholesterol carrier: it accepts cholesterol from internal lysosomal membranes (a process stimulated by the lysosomal phospholipid LBPA/BMP via direct NPC2-LBPA interaction at the NPC2 hydrophobic knob domain), then docks onto the middle lumenal domain of the membrane protein NPC1 (interaction requiring acidic pH and cholesterol-loaded NPC2) to hand off cholesterol through a direct tunnel to NPC1's N-terminal domain for export to the cytosol; the two proteins act non-redundantly in concert as shown by double-mutant mouse genetics. NPC2 reaches lysosomes via mannose-6-phosphate-dependent sorting through the CI-MPR pathway, which is regulated by the GARP complex, the BORC-ARL8-HOPS ensemble, and TMEM241-mediated UDP-GlcNAc supply for M6P modification; the non-canonical NF-κB2 pathway directly controls NPC2 transcription. Beyond lysosomes, secreted NPC2 stimulates ABCG5/G8-dependent biliary cholesterol secretion, regulates ovarian steroidogenesis by providing cholesterol substrate, controls sperm cholesterol content during epididymal maturation, and in the innate immune context mediates ATRA-induced antimicrobial activity against M. tuberculosis through lysosomal acidification and cholesterol reduction.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"NPC2 is a small soluble lysosomal glycoprotein that serves as the primary intraluminal cholesterol carrier, and its deficiency causes Niemann-Pick type C2 disease, with exogenous recombinant NPC2 rescuing lysosomal cholesterol accumulation in patient fibroblasts [#0]. It binds cholesterol with high affinity in a 1:1 stoichiometry [#1], sequestering the sterol in a deep hydrophobic pocket between two β-sheets with only the polar substituent solvent-exposed and aromatic tunnel-entrance residues essential for function [#2]; binding is selective for cholesterol and closely related sterols over phospholipids, glycolipids, and fatty acids [#7]. NPC2 extracts cholesterol from internal lysosomal membranes through direct protein-membrane contact, a process accelerated by orders of magnitude by the lysosomal phospholipid LBPA/BMP via a direct interaction at the NPC2 hydrophobic knob, while sphingomyelin inhibits and ceramide promotes transfer [#9, #10, #11]. NPC2 then docks onto the middle lumenal domain of NPC1 — an interaction requiring acidic pH and cholesterol-loaded NPC2 — to hand cholesterol through a direct tunnel to NPC1's N-terminal domain for export [#3, #5, #6]; mouse double-mutant genetics establishes that NPC1 and NPC2 act non-redundantly in concert in this egress pathway [#4]. NPC2 reaches lysosomes by mannose-6-phosphate-dependent CI-MPR sorting that depends on TMEM241-supplied UDP-GlcNAc for M6P modification, the GARP complex, and the BORC-ARL8-HOPS ensemble [#21, #13, #22], with Asn-58 glycosylation required for correct targeting [#8], and its transcription is directly driven by the non-canonical NF-κB2 pathway [#20]. Beyond lysosomal egress, secreted NPC2 stimulates ABCG5/G8-dependent biliary cholesterol secretion independently of its lysosomal function [#18], supports ovarian steroidogenesis and sperm maturation by providing cholesterol [#26, #27], and mediates ATRA-induced antimicrobial activity against M. tuberculosis through lysosomal acidification and cholesterol reduction [#24].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Before any function was assigned, it was unknown whether NPC2 acted on lipids directly; demonstrating high-affinity 1:1 cholesterol binding established it as a dedicated cholesterol-binding protein.\",\n      \"evidence\": \"In vitro cholesterol binding assay with purified porcine NPC2 homolog\",\n      \"pmids\": [\"10366780\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding alone did not establish a transport function\", \"Did not reveal the structural basis of recognition\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"It was unclear whether NPC2 directly mediates cholesterol egress; rescue of LDL-cholesterol accumulation in NPC2-deficient fibroblasts by recombinant protein established NPC2 as causally required for lysosomal cholesterol export and the gene behind NPC2 disease.\",\n      \"evidence\": \"Fibroblast complementation with recombinant protein, mutation analysis\",\n      \"pmids\": [\"11125141\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the molecular partner receiving cholesterol\", \"Mechanism of membrane extraction unresolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Whether NPC1 and NPC2 act in the same pathway or in parallel was unresolved; identical single- and double-mutant mouse phenotypes provided genetic evidence they function non-redundantly in concert.\",\n      \"evidence\": \"NPC1;NPC2 double-mutant mouse genetics with biochemical and histopathological readouts\",\n      \"pmids\": [\"15071184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genetic epistasis did not show physical handoff\", \"Order and directionality of transfer not established\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"The basis of NPC2 lysosomal targeting was unknown; mutagenesis showed glycosylation at Asn-58 specifically directs NPC2 to lysosomes and is required for its trafficking function.\",\n      \"evidence\": \"Site-directed mutagenesis of glycosylation sites with localization and complementation in NPC2-/- fibroblasts\",\n      \"pmids\": [\"15542393\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not identify the sorting receptor or machinery\", \"M6P dependence inferred but not directly demonstrated here\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"The breadth of NPC2 ligand specificity and its glycoform heterogeneity were unclear; biochemical profiling defined selective binding to cholesterol and related sterols but not other lipids, and mapped variable N-glycan usage.\",\n      \"evidence\": \"Mass spectrometry, chromatography-based and fluorescence binding assays, endoglycosidase treatment\",\n      \"pmids\": [\"17018531\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not connect specific glycoforms to function\", \"Physiological relevance of each ligand untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"How NPC2 holds cholesterol was unknown at atomic detail; the crystal structure revealed a deep hydrophobic pocket with conformationally mobile aromatic gate residues essential for function.\",\n      \"evidence\": \"X-ray crystallography of apo and sterol-bound bovine NPC2\",\n      \"pmids\": [\"17573352\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not show how the sterol enters or exits\", \"Structure of the NPC1-bound transfer state not defined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"The receiver of NPC2-bound cholesterol was unknown; reconstitution showed NPC2 accelerates bidirectional transfer between NPC1's NTD and membranes >100-fold and that a cholesterol-binding-deficient mutant fails, placing NPC2 as the essential intermediary in handoff to NPC1.\",\n      \"evidence\": \"In vitro [3H]cholesterol transfer assay with purified NPC1-NTD, liposomes, and P120S mutant\",\n      \"pmids\": [\"18772377\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not capture the NPC2-NPC1 docking interface\", \"Directionality in vivo not established\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"How NPC2 engages membranes and what regulates transfer rate was unclear; biophysics demonstrated direct protein-membrane interaction and showed LBPA enhances transfer up to two orders of magnitude.\",\n      \"evidence\": \"Fluorescence and FTIR spectroscopy, tryptophan spectral shifts, cholesterol transfer assays\",\n      \"pmids\": [\"18823126\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not map the LBPA interaction site\", \"Membrane-bound orientation not resolved\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"The lipid context governing NPC2 transfer was undefined; defined-liposome assays showed BMP stimulates and sphingomyelin inhibits transfer while ceramide enhances it, with strong selectivity for cholesterol.\",\n      \"evidence\": \"In vitro liposome cholesterol transfer and membrane fusion assays with defined lipids\",\n      \"pmids\": [\"20179319\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish in vivo lipid regulation\", \"Membrane fusion role physiological relevance untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"How NPC2 transfers cargo to NPC1 mechanistically was unknown; SPR and affinity studies showed NPC1's middle lumenal domain binds NPC2 only at acidic pH with cholesterol bound, and disease mutations weaken binding, defining a regulated docking step.\",\n      \"evidence\": \"Surface plasmon resonance, affinity chromatography, engineered soluble NPC1 domains\",\n      \"pmids\": [\"22065762\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not provide atomic structure of the complex\", \"Tunnel for transfer not visualized\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The structural basis of the handoff was unresolved; the NPC1-MLD/NPC2 co-crystal revealed two protruding loops binding NPC2 and a direct cholesterol transfer tunnel between the two binding pockets, supporting the hydrophobic hand-off model.\",\n      \"evidence\": \"2.4-Å X-ray crystallography of the complex and docking onto full-length NPC1\",\n      \"pmids\": [\"27551080\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Static structure did not capture the transfer in motion\", \"Membrane-embedded NPC1 export step not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Whether sphingomyelin metabolism gates NPC2 function was unclear; ASM-mediated conversion of sphingomyelin to ceramide was shown to be required for physiological NPC2 cholesterol transfer.\",\n      \"evidence\": \"Liposomal cholesterol transfer assays with ASM preincubation\",\n      \"pmids\": [\"25339683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro only, not independently replicated\", \"Cellular consequence of ASM loss on NPC2 not directly tested\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Whether the LBPA stimulation reflects a direct interaction was uncertain; direct binding and domain mapping localized the LBPA interaction to the NPC2 hydrophobic knob and showed LBPA enrichment cannot rescue NPC2-deficient cells, establishing an obligate functional partnership.\",\n      \"evidence\": \"Direct LBPA-NPC2 binding assay, lipid enrichment of patient fibroblasts, domain-mapping mutagenesis\",\n      \"pmids\": [\"31580258\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve the LBPA-binding structure\", \"Stoichiometry of NPC2-LBPA-membrane complex unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The membrane-engaged conformations of NPC2 were inferred but not modeled; MD simulations defined competing Prone and Supine orientations with BMP specifically favoring the uptake-competent Prone mode.\",\n      \"evidence\": \"Atomistic molecular dynamics simulations and free energy calculations\",\n      \"pmids\": [\"29084218\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Computational only, no experimental validation in the same study\", \"Predicted orientations not directly observed structurally\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"The trafficking machinery delivering NPC2 to lysosomes was undefined; a CRISPR screen identified the GARP complex as required for CI-MPR-dependent NPC2 delivery, linking GARP loss to cholesterol accumulation.\",\n      \"evidence\": \"Genome-wide CRISPR screen, siRNA validation, transcriptomics, Vps54 mutant mice\",\n      \"pmids\": [\"28658628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the full sorting receptor cycle\", \"Other trafficking regulators not yet identified\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Additional regulators of NPC2 lysosomal delivery were unknown; depletion of BORC, ARL8, or HOPS reduced NPC2 lysosomal association and increased its secretion via destabilized CI-MPR, without affecting NPC1.\",\n      \"evidence\": \"siRNA knockdown, filipin staining, CI-MPR trafficking and cholesterol esterification assays\",\n      \"pmids\": [\"35653304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Direct interactions among components not mapped\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"How NPC2 acquires its M6P sorting signal was unresolved; a CRISPR screen identified TMEM241 as the Golgi UDP-GlcNAc transporter required for M6P modification and lysosomal targeting of NPC2.\",\n      \"evidence\": \"Genome-wide CRISPR-Cas9 screen, M6P modification assay, TMEM241 KO cells and mice\",\n      \"pmids\": [\"37890669\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not test whether other lysosomal enzymes share this dependence specificity\", \"Tissue selectivity of the phenotype unexplained\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Transcriptional control of NPC2 was unknown; ChIP and loss-of-function across species showed the non-canonical NF-κB2 pathway directly drives NPC2 transcription and that its loss causes cholesterol accumulation.\",\n      \"evidence\": \"ChIP promoter binding, RNAi, qPCR, NF-κB2-deficient zebrafish and mice\",\n      \"pmids\": [\"30091016\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab\", \"Upstream physiological triggers in tissues not defined\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"It was unknown whether NPC2 acts outside lysosomes; detection of secreted NPC2 in bile and plasma, enriched in the cholesterol pro-nucleating bile fraction and upregulated in NPC1-null liver, pointed to an extracellular role.\",\n      \"evidence\": \"Western blotting of bile/plasma fractions, ConA fractionation, NPC1 KO mice\",\n      \"pmids\": [\"16374838\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional role in bile only inferred\", \"Mechanism of secretion not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Whether secreted NPC2 functionally affects biliary cholesterol was untested; mouse genetics showed NPC2 stimulates ABCG5/G8-mediated biliary cholesterol efflux, requiring those transporters and independent of its lysosomal function.\",\n      \"evidence\": \"Adenoviral hepatic knockdown/overexpression, biliary lipid analysis, ABCG5/G8-null mice\",\n      \"pmids\": [\"21315718\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular interaction between NPC2 and ABCG5/G8 not shown\", \"Whether NPC2 delivers cholesterol to the transporters undefined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"A physiological role for NPC2 in steroidogenic tissue was unknown; NPC2-deficient female mice showed anovulation, low estradiol, and ovarian cholesterol accumulation, implicating NPC2 in cholesterol export for steroid synthesis.\",\n      \"evidence\": \"NPC2 KO mice, immunohistochemistry, hormone assays, superovulation\",\n      \"pmids\": [\"19883728\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of cholesterol delivery to steroidogenic machinery not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Whether NPC2 governs sperm cholesterol was unknown; NPC2-/- epididymal sperm showed reduced cholesterol, abnormal capacitation-associated phosphorylation, and impaired fertilization, defining a role in epididymal maturation.\",\n      \"evidence\": \"NPC2 KO mice, cholesterol quantification, tyrosine phosphorylation Western blot, IVF assay\",\n      \"pmids\": [\"24709320\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct cholesterol transfer to sperm membranes not demonstrated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A role for NPC2 in innate immunity was unexplored; NPC2 knockdown abolished ATRA-induced cholesterol reduction, lysosomal acidification, and antimicrobial killing of M. tuberculosis.\",\n      \"evidence\": \"siRNA knockdown, cholesterol and lysosomal acidification assays, intracellular M. tuberculosis killing\",\n      \"pmids\": [\"24501203\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking cholesterol to acidification and killing not fully defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Whether tumor-secreted NPC2 has a signaling role was unknown; NPC2 taken up by immature myeloid cells suppressed CCL6 secretion via lysosomal degradation, restraining CCR1-dependent recruitment to premalignant lung tissue.\",\n      \"evidence\": \"NPC2 KO/overexpression mouse lung tumor model, ex vivo secretion assays, IMC recruitment in vivo\",\n      \"pmids\": [\"26183450\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of CCL6 degradation control not detailed\", \"Generality beyond this model unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"How NPC1 status affects NPC2 was unclear; fractionation showed NPC1 mutation causes NPC2 to accumulate, become upregulated, and shift toward membrane association in storage organelles.\",\n      \"evidence\": \"Magnetic chromatography of late endosomes, Western blot, immunofluorescence\",\n      \"pmids\": [\"12554680\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Did not establish whether membrane shift is cause or consequence\", \"Single lab\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"The cellular lipid and organelle consequences of NPC2 loss beyond cholesterol were unclear; an NPC2-/- model showed accumulation of sphingolipids, reduced mitochondria-lysosome contacts, and swollen acidic compartments without oxidative stress.\",\n      \"evidence\": \"NPC2-/- HEK cells, lipidomics, contact site quantification, morphology analysis\",\n      \"pmids\": [\"39747180\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal link between cholesterol block and sphingolipid accumulation not dissected\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The mechanism coupling NPC2 cholesterol handling to organelle membrane contact sites and how its diverse extracellular functions are coordinated with its lysosomal role remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structure of the membrane-engaged NPC2 transfer state\", \"Mechanism of NPC2-ABCG5/G8 cooperation undefined\", \"Integration of innate-immune and reproductive roles with core trafficking unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [1, 2, 7, 9, 11]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [3, 9, 11]},\n      {\"term_id\": \"GO:0140313\", \"supporting_discovery_ids\": [2, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005764\", \"supporting_discovery_ids\": [0, 8, 13, 21, 22]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [14, 15, 28]},\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [17, 18, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [0, 3, 18]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [8, 13, 21, 22]},\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [13, 22]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"NPC1\", \"LBPA/BMP\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}